Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for February 19, 2013
Teva Pharmaceutical Industries Limited ( TEVA ) will begin trading ex-dividend on February 19, 2013. A cash dividend payment of $0.31 per share is scheduled to be paid on March 07, 2013. Shareholders who purchased TEVA stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 20.62% increase over the prior quarter.
The previous trading day's last sale of TEVA was $38.73, representing a -16.49% decrease from the 52 week high of $46.38 and a 5.73% increase over the 52 week low of $36.63.
TEVA is a part of the Consumer Durables sector, which includes companies such as Johnson & Johnson ( JNJ ) and Pfizer, Inc. ( PFE ). TEVA's current earnings per share, an indicator of a company's profitability, is $2.24. Zacks Investment Research reports TEVA's forecasted earnings growth in 2013 as -4.92%, compared to an industry average of -13.7%.
For more information on the declaration, record and payment dates, visit the TEVA Dividend History page.
Interested in gaining exposure to TEVA through an Exchange
Traded Fund [ETF]?
The following ETF(s) have TEVA as a top-10 holding:
- iShares MSCI ACWI ex US Health Care Sector Index Fund ( AXHE )
- iShares MSCI Israel Capped Investable Market Index Fund ( EIS )
- BLDRS Europe 100 ADR Index Fund ( ADRU ).
The top-performing ETF of this group is ADRU with an increase of 15.39% over the last 100 days. AXHE has the highest percent weighting of TEVA at 3.02%.